Literature DB >> 34657131

Relationship between blood pressure repeatedly measured by a wrist-cuff oscillometric wearable blood pressure monitoring device and left ventricular mass index in working hypertensive patients.

Kazuomi Kario1, Naoko Tomitani2, Tomoko Morimoto2, Hiroshi Kanegae2,3, Peter Lacy4, Bryan Williams4.   

Abstract

This study sought to evaluate the relationship between blood pressure (BP) taken by a new wrist-cuff oscillometric wearable BP monitoring device and left ventricular mass index measured by cardiac magnetic resonance imaging (cMRI-LVMI) in 50 hypertensive patients (mean age 60.5 ± 8.9 years, 92.0% men, 96% treated for hypertension) with regular employment. Participants were asked to self-measure their wearable BPs twice in the morning and evening under a guideline-recommended standardized home BP measurement, and once each at five predetermined times and any additional time points under an ambulatory condition for a maximum of 7 days. In total, 2105 wearable BP measurements (home BP: 747 [morning: 409, evening: 338], ambulatory condition: 1358 [worksite: 942]) were collected over 5.5 ± 1.2 days. The average of all wearable systolic BP (SBP) readings (129.8 ± 11.0 mmHg) was weakly correlated with cMRI-LVMI (r = 0.265, p = 0.063). Morning home wearable SBP average (128.5 ± 13.8 mmHg) was significantly correlated with cMRI-LVMI (r = 0.378, p = 0.013), but ambulatory wearable SBP average (132.5 ± 12.7 mmHg) was not (r = 0.215, p = 0.135). The averages of the highest three values of all wearable SBPs (153.3 ± 13.9 mmHg) and ambulatory wearable SBPs (152.9 ± 13.9 mmHg) were 16 mmHg higher than that of the morning home wearable SBPs (137.0 ± 15.9 mmHg). Those peak values were significantly correlated with cMRI-LVMI (r = 0.320, p = 0.023; r = 0.310, p = 0.029; r = 0.451, p = 0.002, respectively). In conclusion, an increased number of wearable BP measurements, which could detect individual peak BP, might add to the clinical value of these measurements as a complement to the guideline-recommended home BP measurements, but further studies are needed to confirm these findings.
© 2021. The Author(s), under exclusive licence to The Japanese Society of Hypertension.

Entities:  

Keywords:  HeartGuide; Left ventricular mass index; Wristwatch-type wearable BP monitoring

Mesh:

Year:  2021        PMID: 34657131     DOI: 10.1038/s41440-021-00758-3

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  5 in total

1.  Latest hypertension research to inform clinical practice in Asia.

Authors:  Kazuomi Kario; Masaki Mogi; Satoshi Hoshide
Journal:  Hypertens Res       Date:  2022-04-05       Impact factor: 5.528

Review 2.  Seven-action approaches for the management of hypertension in Asia - The HOPE Asia network.

Authors:  Kazuomi Kario; Yook-Chin Chia; Saulat Siddique; Yuda Turana; Yan Li; Chen-Huan Chen; Jennifer Nailes; Minh Van Huynh; Peera Buranakitjaroen; Hao-Min Cheng; Takeshi Fujiwara; Satoshi Hoshide; Michiaki Nagai; Sungha Park; Jinho Shin; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Apichard Sukonthasarn; Jam Chin Tay; Boon Wee Teo; Kelvin Tsoi; Narsingh Verma; Tzung-Dau Wang; Yuqing Zhang; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-02-16       Impact factor: 3.738

3.  Nocturnal blood pressure surge in seconds is a new determinant of left ventricular mass index.

Authors:  Ayako Kokubo; Mitsuo Kuwabara; Yuki Ota; Naoko Tomitani; Shingo Yamashita; Toshikazu Shiga; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-12-21       Impact factor: 3.738

Review 4.  Update on Hypertension Research in 2021.

Authors:  Masaki Mogi; Tatsuya Maruhashi; Yukihito Higashi; Takahiro Masuda; Daisuke Nagata; Michiaki Nagai; Kanako Bokuda; Atsuhiro Ichihara; Yoichi Nozato; Ayumi Toba; Keisuke Narita; Satoshi Hoshide; Atsushi Tanaka; Koichi Node; Yuichi Yoshida; Hirotaka Shibata; Kenichi Katsurada; Masanari Kuwabara; Takahide Kodama; Keisuke Shinohara; Kazuomi Kario
Journal:  Hypertens Res       Date:  2022-07-05       Impact factor: 5.528

5.  The HOPE Asia network 2022 up-date consensus statement on morning hypertension management.

Authors:  Kazuomi Kario; Ji-Guang Wang; Yook-Chin Chia; Tzung-Dau Wang; Yan Li; Saulat Siddique; Jinho Shin; Yuda Turana; Peera Buranakitjaroen; Chen-Huan Chen; Hao-Min Cheng; Minh Van Huynh; Jennifer Nailes; Apichard Sukonthasarn; Yuqing Zhang; Jorge Sison; Arieska Ann Soenarta; Sungha Park; Guru Prasad Sogunuru; Jam Chin Tay; Boon Wee Teo; Kelvin Tsoi; Narsingh Verma; Satoshi Hoshide
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-09       Impact factor: 2.885

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.